PPAR-γ and tollip are associated with toll-like receptors in colitis rats

Ning Xu1, Zhen-hai Yu, Qing-shou Yao

  • 1Department of Gastroenterology , Affiliated Yantai Yu Huang Ding Hospital of Qingdao University Medical School, Yantai, PR China.

Insights

This study reveals that an imbalance between Toll-like receptors (TLRs) and their negative regulators, PPAR-γ and Tollip, is linked to colitis pathogenesis. Increased TLRs and decreased PPAR-γ/Tollip expression correlate with disease severity in a rat model.

Area of Science:

  • Immunology
  • Gastroenterology
  • Molecular Biology

Background:

  • Colitis pathogenesis involves complex inflammatory pathways.
  • Toll-like receptors (TLRs) play a crucial role in innate immunity and inflammation.
  • PPAR-γ and Tollip are known negative regulators of inflammatory responses.

Purpose of the Study:

  • To investigate the role of TLRs (TLR2, TLR4) and their negative regulators (PPAR-γ, Tollip) in the pathogenesis of colitis.
  • To determine the correlation between the expression of these molecules and the severity of colitis.

Main Methods:

  • A TNBS-induced colitis model in rats was utilized.
  • Immunohistochemistry (IHC) and reverse-transcription polymerase chain reaction (RT-PCR) were employed to assess gene and protein expression.
  • Expression levels of TLR2, TLR4, NF-κBp65, PPAR-γ, and Tollip were quantified.

Main Results:

  • RT-PCR showed significantly increased expression of TLR2, TLR4, and NF-κBp65 in colitis rats compared to controls.
  • PPAR-γ expression was significantly lower in colitis rats, while Tollip mRNA showed no significant difference, though protein levels were higher.
  • Increased TLRs and NF-κBp65, and decreased PPAR-γ and Tollip, were positively correlated with colitis damage and histological scores.

Conclusions:

  • An imbalance between TLRs and their negative regulators, PPAR-γ and Tollip, is closely associated with the development and progression of colitis.
  • These findings highlight potential therapeutic targets for managing colitis.

Related Concept Videos

Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...